219 related articles for article (PubMed ID: 28803179)
41. Outcome of gamma knife radiosurgery for metastatic brain tumors derived from non-small cell lung cancer.
Cho KR; Lee MH; Kong DS; Seol HJ; Nam DH; Sun JM; Ahn JS; Ahn MJ; Park K; Kim ST; Lim DH; Lee JI
J Neurooncol; 2015 Nov; 125(2):331-8. PubMed ID: 26373297
[TBL] [Abstract][Full Text] [Related]
42. Brain metastases in lung cancer.
Gaspar LE
Expert Rev Anticancer Ther; 2004 Apr; 4(2):259-70. PubMed ID: 15056056
[TBL] [Abstract][Full Text] [Related]
43. Gamma knife radiosurgery for treatment of cerebral metastases from non-small-cell lung cancer.
Motta M; del Vecchio A; Attuati L; Picozzi P; Perna L; Franzin A; Bolognesi A; Cozzarini C; Calandrino R; Mortini P; di Muzio N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e463-8. PubMed ID: 21530098
[TBL] [Abstract][Full Text] [Related]
44. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.
Mamon HJ; Yeap BY; Jänne PA; Reblando J; Shrager S; Jaklitsch MT; Mentzer S; Lukanich JM; Sugarbaker DJ; Baldini EH; Berman S; Skarin A; Bueno R
J Clin Oncol; 2005 Mar; 23(7):1530-7. PubMed ID: 15735128
[TBL] [Abstract][Full Text] [Related]
45. PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
Zinner RG; Obasaju CK; Spigel DR; Weaver RW; Beck JT; Waterhouse DM; Modiano MR; Hrinczenko B; Nikolinakos PG; Liu J; Koustenis AG; Winfree KB; Melemed SA; Guba SC; Ortuzar WI; Desaiah D; Treat JA; Govindan R; Ross HJ
J Thorac Oncol; 2015 Jan; 10(1):134-42. PubMed ID: 25371077
[TBL] [Abstract][Full Text] [Related]
46. Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases.
Novello S; Camps C; Grossi F; Mazieres J; Abrey L; Vernejoux JM; Thall A; Patyna S; Usari T; Wang Z; Chao RC; Scagliotti G
J Thorac Oncol; 2011 Jul; 6(7):1260-6. PubMed ID: 21610524
[TBL] [Abstract][Full Text] [Related]
47. Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome.
Rancoule C; Vallard A; Guy JB; Espenel S; Diao P; Chargari C; Magné N
Crit Rev Oncol Hematol; 2017 Aug; 116():32-37. PubMed ID: 28693798
[TBL] [Abstract][Full Text] [Related]
48. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
[TBL] [Abstract][Full Text] [Related]
49. Timing and risk factors for new brain metastasis formation in patients initially treated only with Gamma Knife surgery. Clinical article.
Sheehan JP; Yen CP; Nguyen J; Rainey JA; Dassoulas K; Schlesinger DJ
J Neurosurg; 2011 Mar; 114(3):763-8. PubMed ID: 20225924
[TBL] [Abstract][Full Text] [Related]
50. Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer.
Urata Y; Okamoto I; Takeda M; Hattori Y; Okuno K; Shimada T; Kurata T; Kaneda H; Miyazaki M; Terashima M; Tanaka K; Morita S; Nakagawa K; Negoro S; Satouchi M
Cancer; 2013 Jun; 119(12):2275-81. PubMed ID: 23558513
[TBL] [Abstract][Full Text] [Related]
51. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
[TBL] [Abstract][Full Text] [Related]
52. Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases: Secondary Analysis of the JROSG 99-1 Randomized Clinical Trial.
Aoyama H; Tago M; Shirato H;
JAMA Oncol; 2015 Jul; 1(4):457-64. PubMed ID: 26181254
[TBL] [Abstract][Full Text] [Related]
53. Impact of time of day on outcomes after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Badiyan SN; Ferraro DJ; Yaddanapudi S; Drzymala RE; Lee AY; Silver SA; Dyk P; DeWees T; Simpson JR; Rich KM; Robinson CG
Cancer; 2013 Oct; 119(19):3563-9. PubMed ID: 23839874
[TBL] [Abstract][Full Text] [Related]
54. Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer: clinical implications for the subsequent management of the brain.
Chen AM; Jahan TM; Jablons DM; Garcia J; Larson DA
Cancer; 2007 Apr; 109(8):1668-75. PubMed ID: 17342770
[TBL] [Abstract][Full Text] [Related]
55. Comparison of two dose levels of stereotactic radiosurgery for 1-3 brain metastases from non-small cell lung cancer.
Rades D; Huttenlocher S; Dahlke M; Hornung D; Blanck O; Van Thai P; Trang NT; Khoa MT; Schild SE
Anticancer Res; 2014 Dec; 34(12):7309-13. PubMed ID: 25503165
[TBL] [Abstract][Full Text] [Related]
56. Lethal intratumoral haemorrhages of brain metastases during radiosurgery: case reports and literature review.
Salek MA; Karlsson B; Yeo TT; Hanssens P; Ning C
Acta Neurochir (Wien); 2013 Jan; 155(1):115-8. PubMed ID: 23053282
[TBL] [Abstract][Full Text] [Related]
57. Early Gamma Knife stereotactic radiosurgery to the tumor bed of resected brain metastasis for improved local control.
Iorio-Morin C; Masson-Côté L; Ezahr Y; Blanchard J; Ebacher A; Mathieu D
J Neurosurg; 2014 Dec; 121 Suppl():69-74. PubMed ID: 25434939
[TBL] [Abstract][Full Text] [Related]
58. Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer.
Patel JD; Hensing TA; Rademaker A; Hart EM; Blum MG; Milton DT; Bonomi PD
J Clin Oncol; 2009 Jul; 27(20):3284-9. PubMed ID: 19433684
[TBL] [Abstract][Full Text] [Related]
59. Radiosurgery for non-small cell lung carcinoma metastatic to the brain: long-term outcomes and prognostic factors influencing patient survival time and local tumor control.
Sheehan JP; Sun MH; Kondziolka D; Flickinger J; Lunsford LD
J Neurosurg; 2002 Dec; 97(6):1276-81. PubMed ID: 12507123
[TBL] [Abstract][Full Text] [Related]
60. Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases.
Garsa AA; Badiyan SN; DeWees T; Simpson JR; Huang J; Drzymala RE; Barani IJ; Dowling JL; Rich KM; Chicoine MR; Kim AH; Leuthardt EC; Robinson CG
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):407-13. PubMed ID: 25084610
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
